Skip to content
  • Sunday, June 8, 2025

VRT Pharma

Regulatory and Clinical Strategy Consulting

  • Home
  • About Us
  • Fields and Areas of Specialization
    • Regulatory Strategy
    • Quality Assurance Consulting
    • Project Management
  • Media
    • Press Releases
  • Career
  • Contact Us
  • Home
  • 2024
  • January

Month: January 2024

Press Release

Healthcare sector advocates for innovation, infrastructure boost, and NCD Focus in Budget 2024-25

January 26, 2024
sarat puli

As India gears up for the Interim Budget 2024-25, the healthcare industry has presented a clear…

Press Release

Zydus gets USFDA nod for Gabapentin tablets (once-daily), 300 mg and 600 mg

January 26, 2024
sarat puli

Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) to…

Press Release

US FDA approves Dupixent to treat younger kids with esophageal condition

January 26, 2024
sarat puli

Jan 25 (Reuters) – The U.S. health regulator has approved the use of Regeneron (REGN.O), opens new…

Recent Posts

  • Healthcare sector advocates for innovation, infrastructure boost, and NCD Focus in Budget 2024-25
  • Zydus gets USFDA nod for Gabapentin tablets (once-daily), 300 mg and 600 mg
  • US FDA approves Dupixent to treat younger kids with esophageal condition

Categories

  • Press Release

You may Missed

Press Release

Healthcare sector advocates for innovation, infrastructure boost, and NCD Focus in Budget 2024-25

January 26, 2024
sarat puli
Press Release

Zydus gets USFDA nod for Gabapentin tablets (once-daily), 300 mg and 600 mg

January 26, 2024
sarat puli
Press Release

US FDA approves Dupixent to treat younger kids with esophageal condition

January 26, 2024
sarat puli
Copyright © 2025 VRT Pharma
Theme by: Theme Horse
Proudly Powered by: WordPress